"

亚搏体育客户端app-亚搏体育官方网站app-亚搏手机版app官网下载拥有全球最顶尖的原生APP,每天为您提供千场精彩体育赛事,亚搏体育客户端app-亚搏体育官方网站app-亚搏手机版app官网下载更有真人、彩票、电子老虎机、真人电子竞技游戏等多种娱乐方式选择,亚搏体育客户端app-亚搏体育官方网站app-亚搏手机版app官网下载让您尽享娱乐、赛事投注等,且无后顾之忧!

                  "
                  Latest news from group

                  Research and
                  development Center

                  R&D overview

                  The company is currently one of the main bases for the production of domestic anti-drug resistant antibiotics and fluoroquinolone antibiotics. It is anti-drug resistant antibiotics, fluoroquinolone antibiotics, antimalarials, glycosidase inhibitors, diabetes drugs, immunosuppressive drugs, etc. It has certain advantages in

                  R&D, production and market development, and has strong international competitiveness.

                  The company attaches great importance to original research and technological innovation with independent intellectual property rights. It has established two technical platforms for industrial green chemistry and microencapsulation of active ingredients in the field of vitamin products, and has established distinctive

                  Read more
                  • 563

                    563domestic
                    invention patents

                  • 164

                    International
                    invention patent

                  • 259

                    259 domestic
                    invention patents